| Target Price | HK$11.42 |
| Price | HK$7.72 |
| Potential |
47.98%
register free of charge
|
| Number of Estimates | 26 |
|
26 Analysts have issued a price target CSPC Pharmaceutical Group Limited 2026 .
The average CSPC Pharmaceutical Group Limited target price is HK$11.42.
This is
47.98%
register free of charge
HK$18.27
136.66%
register free of charge
HK$5.96
22.81%
register free of charge
|
|
| A rating was issued by 32 analysts: 22 Analysts recommend CSPC Pharmaceutical Group Limited to buy, 7 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the CSPC Pharmaceutical Group Limited stock has an average upside potential 2026 of
47.98%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion HK$ | 31.79 | 32.24 |
| 7.76% | 1.41% | |
| EBITDA Margin | 24.03% | 28.73% |
| 10.70% | 19.56% | |
| Net Margin | 14.92% | 18.12% |
| 20.11% | 21.45% |
28 Analysts have issued a sales forecast CSPC Pharmaceutical Group Limited 2025 . The average CSPC Pharmaceutical Group Limited sales estimate is
This results in the following potential growth metrics:
28 CSPC Pharmaceutical Group Limited Analysts have issued a net profit forecast 2025. The average CSPC Pharmaceutical Group Limited net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share HK$ | 0.40 | 0.51 |
| 25.93% | 27.50% | |
| P/E | 14.93 | |
| EV/Sales | 2.45 |
28 Analysts have issued a CSPC Pharmaceutical Group Limited forecast for earnings per share. The average CSPC Pharmaceutical Group Limited EPS is
This results in the following potential growth metrics and future valuations:
CSPC Pharmaceutical Group Limited...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


